Gene Therapy Using Nanocarriers for Pancreatic Ductal Adenocarcinoma: Applications and Challenges in Cancer Therapeutics

Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers worldwide, and its incidence is increasing. PDAC often shows resistance to several therapeutic modalities and a higher recurrence rate after surgical treatment in the early localized stage. Combination chemotherapy in advanced...

Descripción completa

Detalles Bibliográficos
Autores principales: Won, Eun-Jeong, Park, Hyeji, Yoon, Tae-Jong, Cho, Young-Seok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780888/
https://www.ncbi.nlm.nih.gov/pubmed/35057033
http://dx.doi.org/10.3390/pharmaceutics14010137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780888/
https://www.ncbi.nlm.nih.gov/pubmed/35057033
http://dx.doi.org/10.3390/pharmaceutics14010137

Ejemplares similares